Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
11/07/2012 | CN101528710B Aminomethyl-4-imidazoles |
11/07/2012 | CN101528707B 2-[1-phenyl-5-hydroxy or methoxy-4alpha-methyl-hexahydroclopenta[f]indazol-5-yl]ethyl phenyl derivatives as glucocorticoid receptor ligands |
11/07/2012 | CN101524399B Compound and preparation method and application thereof |
11/07/2012 | CN101519345B Trans-3,5-dihydroxyl-4'-bromo butoxyl toluylene as well as preparation and application thereof |
11/07/2012 | CN101518521B New medical application of cedrol |
11/07/2012 | CN101497603B Benzimidazole derivative containing alkoxy alkanamine oxyl substituted pyridine |
11/07/2012 | CN101491668B Composition with blood-sugar reducing function and preparation method thereof |
11/07/2012 | CN101448802B Acrylamide derivative as histone deacetylase inhibitors for cancer treatment |
11/07/2012 | CN101415422B Anti-cancer pharmaceutical composition |
11/07/2012 | CN101402583B Levorotation carnitine acid calcium phosphate, preparation method and use thereof |
11/07/2012 | CN101380313B Famotidine high density type gastric retention osmotic pump controlled release preparation and preparation method thereof |
11/07/2012 | CN101356971B Anti-fatigue anti-hypoxia health food composition |
11/07/2012 | CN101353664B siRNA molecule expression vector for specific inhibition of IL-6 receptor protein expression, and construction method and use thereof |
11/07/2012 | CN101312656B Food supplement |
11/07/2012 | CN101284881B Coarse powder of glucomannan |
11/07/2012 | CN101268047B Crystalline and amorphous sodium atorvastatin |
11/07/2012 | CN101264121B Blood fat reducing health products and preparation |
11/07/2012 | CN101247736B Compositions and methods for improving integrity of functional blood vessel, cellular survival and decreasing Programmed cell death in ischemia or after ischemia in the brain |
11/07/2012 | CN101242839B Azaindazole compounds and methods of use |
11/07/2012 | CN101234117B Medical use of a pair of ginseng saponin aglycones and their mixture |
11/07/2012 | CN101217946B Formulations of water insoluble or poorly water soluble drugs in lipidated glycosaminoglycan particles and their pharmaceutical use |
11/07/2012 | CN101203245B Injection formula for RNA |
11/07/2012 | CN101198309B Use of hair protection composition in preparing hair protection agent |
11/07/2012 | CN101193561B Dietary fiber composition comprising glucomannan, xanthan gum, and alginate |
11/07/2012 | CN101171009B Use of non-imidazole alkylamines histamine h3- receptor ligands in treatment of parkinson's disease obstructive sleep apnea, dementia with lewy bodies, vascular dementia |
11/07/2012 | CN101166719B Bcrp/abcg2 inhibitor |
11/07/2012 | CN101155781B Pyridine-3-carboxamide derivatives as cb1 inverse agonists |
11/07/2012 | CN101132693B Compositions and methods for the management of hyperproliferative dermatological conditions |
11/07/2012 | CN101120926B Freezing-dried preparation containing voriconazole and its preparation method |
11/07/2012 | CN101117328B Fatty acid synthetase inhibitor and application for treating bacterial infection |
11/07/2012 | CN101074223B Versulin derivative and its use in treatment of diabetes and its complication |
11/07/2012 | CN101066260B Coenzyme Q10 emulsion and its freeze dried emulsion and their preparation process |
11/07/2012 | CN101062024B Pronin medicinal composition and its preparing method |
11/07/2012 | CN101057834B Solid preparation comprising enteric solid dispersion |
11/07/2012 | CN101001846B Novel alkynyl derivatives as modulators of metabotropic glutamate receptors |
11/07/2012 | CN101001837B Indole derivatives comprising an acetylene group as PPAR activators |
11/06/2012 | USRE43797 Methods of administering tetrahydrobiopterin |
11/06/2012 | US8304557 Fused heterocycle derivatives and use thereof |
11/06/2012 | US8304556 Thiazolyl-dihydro-indazoles |
11/06/2012 | US8304552 Fatty acid niacin conjugates and their uses |
11/06/2012 | US8304551 Fatty acid niacin conjugates and their uses |
11/06/2012 | US8304547 Azolecarboxamide compound or salt thereof |
11/06/2012 | US8304455 Compositions and methods of their use for improving the condition and appearance of skin |
11/06/2012 | US8304454 Antimicrobial cellulose sponge and method of making |
11/06/2012 | US8304453 Composition comprising at least one alkanolamide to inhibit migration of langerhans cells and uses therof |
11/06/2012 | US8304451 Histone deacetylase and tubulin deacetylase inhibitors |
11/06/2012 | US8304450 Stable pharmaceutical compositions with docetaxel |
11/06/2012 | US8304449 Inhibitors of cyclin dependent kinases and their use |
11/06/2012 | US8304448 Method for the treatment of metabolic disorder containing benzazole derivatives as an active ingredient |
11/06/2012 | US8304447 2-acylaminopropoanol-type glucosylceramide synthase inhibitors |
11/06/2012 | US8304446 Compounds |
11/06/2012 | US8304445 7-pyrazolyl tetracycline compounds and methods of use thereof |
11/06/2012 | US8304443 Indazole derivatives |
11/06/2012 | US8304442 Compounds having immunomodulator activity |
11/06/2012 | US8304441 Thiazolidinedione analogues for the treatment of metabolic diseases |
11/06/2012 | US8304440 Combination of a bis-thiazolium salt or a precursor thereof and artemisinin or a derivative thereof for treating acute malaria |
11/06/2012 | US8304439 Use of quaternary pyridinium salts as a therapeutic or preventing agent against ionizing radiation-induced damage |
11/06/2012 | US8304438 Heteroarylacrylamides and their use as pharmaceuticals |
11/06/2012 | US8304437 Carboxamide compound and use of the same |
11/06/2012 | US8304436 Pyrazolone derivatives as PDE4 inhibitors |
11/06/2012 | US8304435 Deuterium-enriched donepezil |
11/06/2012 | US8304434 Substituted aryl sulfone derivatives as calcium channel blockers |
11/06/2012 | US8304433 Crystalline form of a 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compound |
11/06/2012 | US8304432 4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds |
11/06/2012 | US8304431 Use of D4 and 5-HT2A antagonists, inverse agonists or partial agonists |
11/06/2012 | US8304430 Phosphonic acid compounds as inhibitors of serine proteases |
11/06/2012 | US8304429 Methods for preventing and/or treating degenerative disorders of the central nervous system |
11/06/2012 | US8304428 Compounds and methods for inhibiting the interaction of BCL proteins with binding partners |
11/06/2012 | US8304427 Acylthiourea compound or salt thereof, and use thereof |
11/06/2012 | US8304426 Polymorphic form of Granisetron base, methods for obtaining it and formulation containing it |
11/06/2012 | US8304425 Pyrrolidinone, pyrrolidine-2,5-dione, pyrrolidine and thiosuccinimide derivatives, compositions and methods for treatment of cancer |
11/06/2012 | US8304424 Freeze-dried injectable pharmaceutical combination of semisynthetic vinca alkaloids and carbohydrate stable at room temperature |
11/06/2012 | US8304423 Modulators of muscarinic receptors |
11/06/2012 | US8304421 Indole compounds and their use as radiation sensitizing agents and chemotherapeutic agents |
11/06/2012 | US8304420 Substituted quinazolines for reducing platelet count |
11/06/2012 | US8304419 Chemical compounds |
11/06/2012 | US8304418 Pyrazolopyrimidinone kinase inhibitor |
11/06/2012 | US8304417 Crystalline forms of 4-(6-chloro-2,3-methylenedioxyanilino)-7-[2-(4-methylpiperazin-1-yl)ethoxy]-5-tetrahydropyran-4-yloxyquinazoline |
11/06/2012 | US8304416 Chromenone derivatives |
11/06/2012 | US8304415 1, 2-disubstituted amido-anthraquinone derivatives, preparation method and application thereof |
11/06/2012 | US8304414 Pyrazole compounds useful as protein kinase inhibitors |
11/06/2012 | US8304413 Compounds and methods for treating inflammatory and fibrotic disorders |
11/06/2012 | US8304412 Cyclically substituted 3,5-dicyano-2-thiopyridines and use thereof |
11/06/2012 | US8304411 Dicycloazaalkane derivates, preparation processes and medical uses thereof |
11/06/2012 | US8304410 Pyrrole compounds as inhibitors of mycobacteria, synthesis thereof and intermediates thereto |
11/06/2012 | US8304409 Nitrosated nonsteroidal antiinflammatory compounds, compositions and methods of use |
11/06/2012 | US8304408 Wnt signaling inhibitors, and methods for making and using them |
11/06/2012 | US8304407 8-substituted benzoazepines as toll-like receptor modulators |
11/06/2012 | US8304406 Compounds for treating pulmonary hypertension |
11/06/2012 | US8304405 Combination of azelastine and ciclesonide for nasal administration |
11/06/2012 | US8304404 Intravenous formulation with water-soluble cocrystals of acetylsalicylic acid and theanine |
11/06/2012 | US8304403 Heterocyclic CETP inhibitors |
11/06/2012 | US8304402 Composition and method for treating nosebleeds |
11/06/2012 | US8304401 Compositions and methods for decreasing type III deiodinase activity to modulate adiposity and blood glucose levels |
11/06/2012 | US8304400 Compositions and methods for inhibiting tumor growth and metastasis |
11/06/2012 | US8304399 Hedgehog signaling pathway proteins and uses thereof |
11/06/2012 | US8304398 Therapeutic intervention in a genetic disease in an individual by modifying expression of an aberrantly or abnormally expressed gene |
11/06/2012 | US8304396 Immunostimulatory nucleic acids |
11/06/2012 | US8304395 Lipid conjugates in the treatment of disease |
11/06/2012 | US8304394 Low side effect pharmaceutical composition containing isoniazid |